InvestorsHub Logo
Followers 87
Posts 6642
Boards Moderated 1
Alias Born 09/18/2009

Re: Corundum post# 25987

Thursday, 03/11/2021 9:21:59 AM

Thursday, March 11, 2021 9:21:59 AM

Post# of 42751
Thanks, Corundum. It's interesting that with $64M left on the Controlled Equity Offering, and probably and another $50M available from the shelf registration, that they chose to take an $80M loan from Hercules Capital.

I liked being debt free.

Also, the lien is on "company assets," but the Press Release doesn't indicate that the company's Intellectual Property is excluded, as we often see in loans of this type.

I wonder if Hercules is acting on behalf of a venture capital/SPAC group, and if they will want a seat on the Board.

Also, if IR (Richard) told abaj that the controlled offering wasn't effected, then that conflicts with what was disclosed in the 10-K.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162476860

In any event, Humanigen is accumulating some serious firepower, and I can't wait to see how we will benefit once the plans for that money are released. Will it all go to additional clinical tests in the pipeline, or will we end up as the "surviving partner" in a merger (I read something along those lines somewhere)?